Skip to main navigation Skip to search Skip to main content

CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume

  • Emrah Düzel
  • , David Berron
  • , Hartmut Schütze
  • , Arturo Cardenas-Blanco
  • , Coraline Metzger
  • , Matthew Betts
  • , Gabriel Ziegler
  • , Yi Chen
  • , Laura Dobisch
  • , Daniel Bittner
  • , Wenzel Glanz
  • , Martin Reuter
  • , Annika Spottke
  • , Janna Rudolph
  • , Frederic Brosseron
  • , Katharina Buerger
  • , Daniel Janowitz
  • , Klaus Fliessbach
  • , Michael Heneka
  • , Christoph Laske
  • Martina Buchmann, Peter Nestor, Oliver Peters, Dominik Diesing, Siyao Li, Josef Priller, Eike Jakob Spruth, Slawek Altenstein, Alfredo Ramirez, Anja Schneider, Barbara Kofler, Oliver Speck, Stefan Teipel, Ingo Kilimann, Martin Dyrba, Jens Wiltfang, Claudia Bartels, Steffen Wolfsgruber, Michael Wagner, Frank Jessen
  • Otto-von-Guericke University
  • German Center for Neurodegenerative Diseases (DZNE)
  • University College London
  • Magdeburg University Hospital
  • University of Bonn
  • University of Bonn and University Hospital Bonn
  • Ludwig-Maximilians-Universität München
  • University Clinic Tuebingen
  • Charite Universitätsmedizin Berlin
  • Department of Psychiatry and Psychotherapy
  • University of Cologne
  • Department of Biomagnetical Resonance
  • Rostock University Medical Center
  • University Medical Center

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Introduction: We examined the association between cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease, neural novelty responses, and brain volume in predementia old age. Methods: We conducted a cross-sectional analysis of the observational, multicentric DZNE-Longitudinal Cognitive Impairment and Dementia Study (DELCODE) study. Seventy-six participants completed task functional magnetic resonance imaging and provided CSF (40 cognitively unimpaired, 21 experiencing subjective cognitive decline, and 15 with mild cognitive impairment). We assessed the correlation between CSF biomarkers and whole-brain functional magnetic resonance imaging novelty responses to scene images. Results: Total tau levels were specifically and negatively associated with novelty responses in the right amygdala and right hippocampus. Mediation analyses showed no evidence that these associations were dependent on the volume of hippocampus/amygdala. No relationship was found between phosphorylated-tau or Aβ42 levels and novelty responses. Discussion: Our data show that CSF levels of total tau are associated with anatomically specific reductions in novelty processing, which cannot be fully explained by atrophy.

Original languageEnglish
Pages (from-to)782-790
Number of pages9
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume10
DOIs
StatePublished - 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Alzheimer's disease (AD)
  • Apolipoprotein E (APOE)
  • Cerebrospinal fluid (CSF)
  • Longitudinal
  • Magnetic resonance imaging (MRI)
  • Mild cognitive impairment (MCI)
  • Positron emission tomography (PET)
  • Subjective cognitive decline (SCD)
  • Tau

Fingerprint

Dive into the research topics of 'CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume'. Together they form a unique fingerprint.

Cite this